메뉴 건너뛰기




Volumn 89, Issue 10, 2005, Pages 1306-1310

18 Years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma

Author keywords

[No Author keywords available]

Indexed keywords

STRONTIUM 90; STRONTIUM;

EID: 27744471059     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.068460     Document Type: Article
Times cited : (40)

References (30)
  • 1
    • 0027197684 scopus 로고
    • An approach to the management of patients with uveal melanoma
    • Damato BE. An approach to the management of patients with uveal melanoma. Eye 1993;7:388-97.
    • (1993) Eye , vol.7 , pp. 388-397
    • Damato, B.E.1
  • 3
    • 0038692184 scopus 로고    scopus 로고
    • Changing concepts in the management of choroidal melanoma
    • Robertson DM. Changing concepts in the management of choroidal melanoma. Am J Ophthalmol 2003;136:161-70.
    • (2003) Am J Ophthalmol , vol.136 , pp. 161-170
    • Robertson, D.M.1
  • 4
    • 0018398877 scopus 로고
    • Radiotherapie der intraokularen Tumoren, insbesondere bei Aderhautmelanom
    • Lommatzsch PK. Radiotherapie der intraokularen Tumoren, insbesondere bei Aderhautmelanom. Klin Monatsbl Augenheilkd 1979;174:948-58.
    • (1979) Klin Monatsbl Augenheilkd , vol.174 , pp. 948-958
    • Lommatzsch, P.K.1
  • 5
    • 0033489948 scopus 로고    scopus 로고
    • Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma
    • Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 1999;106:1579-87.
    • (1999) Ophthalmology , vol.106 , pp. 1579-1587
    • Wilson, M.W.1    Hungerford, J.L.2
  • 6
    • 0035450791 scopus 로고    scopus 로고
    • Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma
    • Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001;51:138-47.
    • (2001) Int J Radiat Oncol Biol Phys , vol.51 , pp. 138-147
    • Egger, E.1    Schalenbourg, A.2    Zografos, L.3
  • 7
    • 0031920635 scopus 로고    scopus 로고
    • Results of treatment of choroidal malignant melanoma with high-dose-rate strontium-90 brachytherapy
    • Missotten L, Dirven W, Van der Schueren A, et al. Results of treatment of choroidal malignant melanoma with high-dose-rate strontium-90 brachytherapy. Graefes Arch Clin Exp Ophthalmol 1998;236:164-73.
    • (1998) Graefes Arch Clin Exp Ophthalmol , vol.236 , pp. 164-173
    • Missotten, L.1    Dirven, W.2    Van Der Schueren, A.3
  • 8
    • 0031309131 scopus 로고    scopus 로고
    • Results of histopathologic examination of three enucleated eyes with a choroidal melanoma afeter Strontium-90 irradiation
    • Parys-Van Ginderdeuren R, Van den Oord JJ, Missotten L. Results of histopathologic examination of three enucleated eyes with a choroidal melanoma afeter Strontium-90 irradiation. Bull Soc Beige Ophtalmol 1997;265:47-54.
    • (1997) Bull Soc Beige Ophtalmol , vol.265 , pp. 47-54
    • Parys-Van Ginderdeuren, R.1    Van Den Oord, J.J.2    Missotten, L.3
  • 9
    • 0033812517 scopus 로고    scopus 로고
    • Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 consecutive patients
    • Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 2000;118:1219-28.
    • (2000) Arch Ophthalmol , vol.118 , pp. 1219-1228
    • Shields, C.L.1    Shields, J.A.2    Cater, J.3
  • 10
    • 0036895042 scopus 로고    scopus 로고
    • The COMS randomised trial of iodine-125 brachytherapy for choroidal melanoma. IV Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No 19
    • Jampol L, Moy C, Murray T, et al. The COMS randomised trial of iodine-125 brachytherapy for choroidal melanoma. IV Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No 19. Ophthalmology 2002;109:2197-206.
    • (2002) Ophthalmology , vol.109 , pp. 2197-2206
    • Jampol, L.1    Moy, C.2    Murray, T.3
  • 11
    • 0035153825 scopus 로고    scopus 로고
    • Collaborative ocular melanoma study (COMS) randomised trial of 1-125 brachytherapy for medium choroidal melanoma. Visual acuity after 3 years. COMS Report No 16
    • Collaborative Ocular Melanoma Study Group. Collaborative ocular melanoma study (COMS) randomised trial of 1-125 brachytherapy for medium choroidal melanoma. Visual acuity after 3 years. COMS Report No 16. Ophthalmology 2001;108:348-66.
    • (2001) Ophthalmology , vol.108 , pp. 348-366
  • 12
    • 0036789485 scopus 로고    scopus 로고
    • Late radiation failures after iodine 125 brachytherapy of uveal melanoma compared with charged-particle (proton or helium ion) therapy
    • Char D, Kroll S, Phillips T, et al. Late radiation failures after iodine 125 brachytherapy of uveal melanoma compared with charged-particle (proton or helium ion) therapy. Ophthalmology 2002;109:1850-4.
    • (2002) Ophthalmology , vol.109 , pp. 1850-1854
    • Char, D.1    Kroll, S.2    Phillips, T.3
  • 13
    • 0034947333 scopus 로고    scopus 로고
    • Fifteen years of work. The COMS outcomes for medium-sized choroidal melanoma
    • Sieving PA. Fifteen years of work. The COMS outcomes for medium-sized choroidal melanoma. Arch Ophthalmol 2001;119:1067-8.
    • (2001) Arch Ophthalmol , vol.119 , pp. 1067-1068
    • Sieving, P.A.1
  • 14
    • 0026663672 scopus 로고
    • Long-term results of iodine 125 irradiation of uveal melanoma
    • Packer S, Stoller S, Lesser ML, et al. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992;99:767-73.
    • (1992) Ophthalmology , vol.99 , pp. 767-773
    • Packer, S.1    Stoller, S.2    Lesser, M.L.3
  • 15
    • 0037086331 scopus 로고    scopus 로고
    • Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: Dose and dose rate effects
    • Jones R, Gore E, Mieler W, et al. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. Int J Radiation Oncoloqy Biol Phys 2002;52:989-95.
    • (2002) Int J Radiation Oncoloqy Biol Phys , vol.52 , pp. 989-995
    • Jones, R.1    Gore, E.2    Mieler, W.3
  • 16
    • 0032786595 scopus 로고    scopus 로고
    • Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1066 patients
    • Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1066 patients. Acta Opthalmol Scand 1999;77:414-17.
    • (1999) Acta Opthalmol Scand , vol.77 , pp. 414-417
    • Seregard, S.1
  • 17
    • 2342565111 scopus 로고    scopus 로고
    • Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years experience with beta-rays)
    • Rouberol F, Roy P, Kodjikian L, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years experience with beta-rays). Am J Ophthalmol 2004;137:893-900.
    • (2004) Am J Ophthalmol , vol.137 , pp. 893-900
    • Rouberol, F.1    Roy, P.2    Kodjikian, L.3
  • 18
    • 0037296705 scopus 로고    scopus 로고
    • Current trends in the treatment of ocular melanoma by radiotherapy. Gregg Lecture 2001
    • Hungerford J. Current trends in the treatment of ocular melanoma by radiotherapy. Gregg Lecture 2001. Clin Experiment Ophthalmol 2003;31:8-13.
    • (2003) Clin Experiment Ophthalmol , vol.31 , pp. 8-13
    • Hungerford, J.1
  • 19
    • 0030934210 scopus 로고    scopus 로고
    • Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience
    • Seregard S, Trmpe E, Lax I, et al. Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience. Acta Ophthalmol Scand 1997;75:11-16.
    • (1997) Acta Ophthalmol Scand , vol.75 , pp. 11-16
    • Seregard, S.1    Trmpe, E.2    Lax, I.3
  • 20
    • 0029787466 scopus 로고    scopus 로고
    • Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma
    • Summanen P, Immonen I, Kivela T, et al. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol 1996;80:732-9.
    • (1996) Br J Ophthalmol , vol.80 , pp. 732-739
    • Summanen, P.1    Immonen, I.2    Kivela, T.3
  • 21
    • 0022930989 scopus 로고
    • 106Rh) of choroidal melanomas: 20 Years' experience
    • 106Rh) of choroidal melanomas: 20 years' experience. Br J Ophthalmol 1986;70:844-51.
    • (1986) Br J Ophthalmol , vol.70 , pp. 844-851
    • Lommatzsch, P.K.1
  • 22
    • 0022532202 scopus 로고
    • 10 Jahre erfahrung mit der ruthenium-106/rhodium 106-behandlung des malignen melanoms der aderhaut - Bericht über 264 bestrahlte tumoren
    • Guthoff R, von Domarus D, Steinhorst U, et al. 10 Jahre Erfahrung mit der Ruthenium-106/Rhodium 106-Behandlung des malignen Melanoms der Aderhaut - Bericht über 264 bestrahlte Tumoren. Klin Monatsbl Augenheilkd 1986;188:576-83.
    • (1986) Klin Monatsbl Augenheilkd , vol.188 , pp. 576-583
    • Guthoff, R.1    Von Domarus, D.2    Steinhorst, U.3
  • 23
    • 0028889695 scopus 로고
    • Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy
    • Summanen P, Immonen I, Kiveal T, et al. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg Lasers 1995;26:449-60.
    • (1995) Ophthalmic Surg Lasers , vol.26 , pp. 449-460
    • Summanen, P.1    Immonen, I.2    Kiveal, T.3
  • 24
    • 0034810530 scopus 로고    scopus 로고
    • Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: An EORTC ocular oncology group study
    • Pe'er J, Stafani FH, Seregard S, et al. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study. Br J Ophthalmol 2001;85:1208-12.
    • (2001) Br J Ophthalmol , vol.85 , pp. 1208-1212
    • Pe'er, J.1    Stafani, F.H.2    Seregard, S.3
  • 26
    • 0026704176 scopus 로고
    • Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma
    • Messmer E, Bornfeld N, Foerster M, et al. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma. Graefes Arch Clin Exp Ophthalmol 1992;230:391-6.
    • (1992) Graefes Arch Clin Exp Ophthalmol , vol.230 , pp. 391-396
    • Messmer, E.1    Bornfeld, N.2    Foerster, M.3
  • 27
    • 0030928368 scopus 로고    scopus 로고
    • Tumour cell proliferation after failed ruthenium plaque radiotherapy in posterior uveal melanoma
    • Seregard S, Lundell G, Lax I, et al. Tumour cell proliferation after failed ruthenium plaque radiotherapy in posterior uveal melanoma. Acta Ophthalmol Scand 1997;75:148-54.
    • (1997) Acta Ophthalmol Scand , vol.75 , pp. 148-154
    • Seregard, S.1    Lundell, G.2    Lax, I.3
  • 28
    • 0142200859 scopus 로고    scopus 로고
    • Very long term prognosis of patients with malignant uveal melanoma
    • Kujala E, Makitie T, Kivela T. Very long term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651-9.
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , pp. 4651-4659
    • Kujala, E.1    Makitie, T.2    Kivela, T.3
  • 29
    • 0034933028 scopus 로고    scopus 로고
    • The COMS randomised trial of Iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No 18
    • Collaborative Ocular Melanoma Study Group. The COMS randomised trial of Iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No 18. Arch Ophthalmol 2001;119:969-82.
    • (2001) Arch Ophthalmol , vol.119 , pp. 969-982
  • 30
    • 0037678425 scopus 로고    scopus 로고
    • Mortality after deferral of treatment or No treatment for choroidal melanoma
    • Straatsma B, Diener-West M, Caldwell R, et al. Mortality after deferral of treatment or No treatment for choroidal melanoma. Am J Ophthalmol 2003;136:47-54.
    • (2003) Am J Ophthalmol , vol.136 , pp. 47-54
    • Straatsma, B.1    Diener-West, M.2    Caldwell, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.